Urologic Oncology Research Training Grant

泌尿肿瘤学研究培训补助金

• 批准号: 6845175
• 负责人: PETER T SCARDINO
• 金额: $ 22.45万
• 依托单位: SLOAN-KETTERING INST CAN RESEARCH
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-09-01 至 2010-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6845175
• 关键词: Urologic; Oncology; Research; Training; Grant

DESCRIPTION (provided by applicant): The Research Training Program (RTP) in Urologic Oncology at MSKCC is designed to train academic leaders in urologic oncology. Over 180 fellows have been trained since the fellowship program was established nearly 50 years ago. Each year 8-15 highly qualified candidates are interviewed from a pool of 25-40 applicants, 3-9 are accepted as post-doctoral fellows, all board-eligible urologists who have completed residency. Two of these are selected each year as research career awardees supported by our T32 training grant, initially funded in 1999, to spend 2 years in research with a senior scientist mentor at MSKCC, Weill Medical College of Cornell University or Rockefeller University, in an appropriate field such as immunology, biological imaging, molecular genetics, or biostatistics. Specific research projects have included adoptive immunotherapy with genetically modify T lymphocytes, monoclonal antibodies against PSMA as imaging and therapeutic agents, and gene expression analysis of prostate cancers. Of 11 fellows appointed to date, 4 are in training, 7 have graduated, and 6 are now assistant professors at major universities. Fellows are required to participate in structured, multidisciplinary clinical and research conferences and to present their work at MSKCC seminars and national meetings. They receive formal instruction in clinical research methodology, biostatistics, research ethics, and human subjects regulatory issues. Our program has grown substantially since the original award. The faculty in urology has doubled, the quality and diversity of research mentors has increased and the number and quality of fellowship applicants have grown steadily. The RTP in urologic oncology is essential to our fellowship, supporting urologists committed to research training to prepare for a career as independent investigators. Our experience over 50 years confirms that they will become leaders of urologic oncology in the next generation whose work will help decrease morbidity from GU cancers.

描述（由申请人提供）：MSKCC泌尿肿瘤学研究培训计划（RTP）旨在培训泌尿肿瘤学的学术带头人。 自近50年前设立奖学金计划以来，已有180多名研究员接受了培训。 每年从25-40名申请者中面试8-15名高素质的候选人，3-9名被接受为博士后研究员，所有符合董事会资格的泌尿科医生都已完成住院医师资格。 其中两人每年被选为研究职业获奖者，由我们的T32培训补助金支持，最初于1999年资助，与MSKCC，康奈尔大学威尔医学院或洛克菲勒大学的高级科学家导师一起在适当的领域进行研究，如免疫学，生物成像，分子遗传学或生物统计学。 具体的研究项目包括采用遗传修饰的T淋巴细胞进行过继免疫治疗，抗PSMA的单克隆抗体作为成像和治疗剂，以及前列腺癌的基因表达分析。 在迄今任命的11名研究员中，4人正在接受培训，7人已经毕业，6人现在是主要大学的助理教授。 研究员必须参加结构化的、多学科的临床和研究会议，并在MSKCC研讨会和全国会议上展示他们的工作。 他们接受临床研究方法学，生物统计学，研究伦理学和人类受试者监管问题的正式指导。 我们的项目自最初获奖以来已经大幅增长。 泌尿外科的教师增加了一倍，研究导师的质量和多样性有所增加，奖学金申请人的数量和质量稳步增长。 在泌尿肿瘤RTP是必不可少的，我们的奖学金，支持泌尿科医生致力于研究培训，为职业生涯作为独立的研究人员做好准备。 我们50多年的经验证实，他们将成为下一代泌尿肿瘤学的领导者，他们的工作将有助于降低GU癌症的发病率。